Sorrento Therapeutics Inc
OTC:SRNE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Sorrento Therapeutics Inc
OTC:SRNE
|
US |
|
A
|
Afi Properties Ltd
TASE:AFPR
|
IL |
|
U
|
Universal Health Realty Income Trust
F:WY8
|
US |
|
Societa Cattolica di Assicurazione SpA
MIL:CASS
|
IT |
|
P
|
Partron Co Ltd
KOSDAQ:091700
|
KR |
|
Quickstep Holdings Ltd
ASX:QHL
|
AU |
|
Bally Corp
OTC:BLYQ
|
CN |
|
Netstreit Corp
NYSE:NTST
|
US |
|
S
|
Shui-Mu International Co Ltd
TWSE:8443
|
TW |
|
Healthier Choices Management Corp
OTC:HCMC
|
US |
|
Parrot SA
PAR:PARRO
|
FR |
|
John B Sanfilippo & Son Inc
NASDAQ:JBSS
|
US |
|
E
|
Eisen und Huettenwerke AG
F:EIS
|
DE |
|
Tesec Corp
TSE:6337
|
JP |
|
Jyothy Labs Ltd
BSE:532926
|
IN |
|
V
|
Vicem But Son Cement JSC
VN:BTS
|
VN |
|
Plus500 Ltd
LSE:PLUS
|
IL |
|
M
|
Magna Polonia SA
WSE:06N
|
PL |
|
S
|
Spectra Systems Corp
LSE:SPSY
|
US |
Bankruptcy Probability
Sorrento Therapeutics Inc's probability of bankruptcy is hidden . The solvency score is hidden .
We take all the information about a company's solvency (such as how easily a company can pay interest on its outstanding debt, how much cash it has, the amount of debt, and more) and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sorrento Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sorrento Therapeutics Inc
OTC:SRNE
|
598.1k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
369.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
173.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
112.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
79.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
44B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
67.2B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sorrento Therapeutics Inc's probability of bankruptcy is hidden .
The probability of bankruptcy is estimated using credit risk models that assess its financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sorrento Therapeutics Inc has total debt of 21.7m USD. This includes both short-term (0 USD) and long-term (21.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
